Use of SLIT in allergy practice: Is it ready for prime time? Stanley Fineman, MD, MBA Atlanta Allergy & Asthma Clinic AAIFNC, Feb 7, 2015

Similar documents
e. Elm Correct Question 2 Which preservative/adjuvant has the greatest potential to breakdown immunotherapy because of protease activity? a.

Introduction. Methods. Results 12/7/2012. Immunotherapy in the Pediatric Population

Quick Guide: SLIT Protocol

Assessing the Relative Risks of Subcutaneous and Sublingual Allergen Immunotherapy

Speaking the Same Language: Grading System for Subcutaneous Immunotherapy Systemic Reaction World Allergy Organization Symposium Immunotherapy &

New Frontiers in Allergen Immunotherapy

Which Factors Might Enhance Safety of Immunotherapy in Your Clinic?

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Allergen Immunotherapy: An Update

Disclosures. Sublingual Immunotherapy for Allergic Disease. Allergy Definition. Learning Objectives. Putting Allergies in Perspective

SLIT: Review and Update

Expert Roundtable on Sublingual Immunotherapy

AEROALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS

The Only Choice that Leaves You in Complete Control

Practical Course Allergen Immunotherapy (AIT) How to be effective. Michel Dracoulakis HSPE- FMO São Paulo-SP Brazil

INVESTIGATIONS & PROCEDURES IN PULMONOLOGY. Immunotherapy in Asthma Dr. Zia Hashim

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet

Accelerated Immunotherapy Schedules: More Convenient? Just As Safe?

Associate Professor Rohan Ameratunga Immunologist & Allergist, Auckland

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Allergy Immunotherapy: A New Role for the Family Physician

Immunotherapy. Chris Doyle Consultant Nurse Respiratory & Allergy Alder Hey Childrens NHS FT. October 18 th 2014

Ten-Year Experience with Sublingual Immunotherapy for Juniper Pollenosis ABSTRACT

GLORIA Module 4: Allergen Specific Immunotherapy Its safe use: A New Zealand perspective

The Current Status of Sublingual Immunotherapy

RECOMMENDATIONS FOR APPROPRIATE SLIT TRIALS

Grastek. Grastek (timothy grass pollen allergen extract) Description. Section: Prescription Drugs Effective Date: January 1, 2018

Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract)

See Important Reminder at the end of this policy for important regulatory and legal information.

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description

Allergen immunotherapy: from EBM to doctors and patients need

What are Allergy shots / SCIT?

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

Allergen Immunotherapy in Asthma: Now and in the Future

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

The Future of Allergy Treatment Ultra-Fast Allergy Immunotherapy

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

As you begin this build-up phase there are several factors to keep in mind concerning your treatment:

Format. Allergic Rhinitis Optimising Mananagement. Degree of Quality of life Restriction in the Allergic Patient. The allergy epidemic:

We improve quality of life by preventing and curing allergy

Corporate Medical Policy Allergy Immunotherapy (Desensitization)

Presentation of ALK London, 24 May 2011 UBS GLOBAL SPECIALTY PHARMACEUTICALS CONFERENCE : LONDON : 24 MAY 2011

The only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses 1

ALK-Abelló A/S. Click View,Header and Footer to change this text to filename and department name

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Prevalence of Fungal Allergy in Patients with Allergic Rhinosinusitis

ImmunoCAP. Specific IgE blood test

New Test ANNOUNCEMENT

A world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP

Allergen Immunotherapy

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Allergen Immunotherapy and Asthma. Linda Cox, MD, FAAAI ASCIA 2013 Meeting

Allergy Therapeutics. Corporate Presentation. Proactive Investors 28th January 2016 Ian Postlethwaite, Finance Director

Ear, Nose & Throat (ENT) - Head & Neck Surgery. Allergic Rhinitis (Sinus)

Face to Face on LAIS Mechanism of action and clinical experiences

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

Allergies & Hypersensitivies

ALK-Abelló Research & Development. Henrik Jacobi MD, EVP Research & Development

Abstract and Introduction.

The Future of Allergy Treatment Ultra-Fast Allergy Immunotherapy

Latest advances in the management of childhood allergic rhinitis

Controlled Studies of Environmental Allergen Remediation in U.S. Homes: Cockroach Allergen

Preventive effect of AIT over the atopic march

Lecture objectives. Definition. Allergen Immunotherapy for Asthma. Effects of Immunotherapy 12/9/2012. Dana V. Wallace, MD. Disclosure Statement

Allergy Testing and Practical Mitigation Measures

Kevin Letz DNP, MSN, MBA, RN, CEN, CNE, FNP-C, PNP-BC, ANP-BC

Secondary prevention of allergic disease. Dr Adam Fox United Kingdom

UNDERSTANDING ALLERGY IMMUNOTHERAPY

ALLERGEN IMMUNOTHERAPY FOR THE TREATMENT OF ALLERGIC RHINITIS AND/OR ASTHMA

New Approaches to Immunotherapy

Discover the connection

Leading R&D pipeline with proven technology. Partners. Injection and drop-based allergy immunotherapy products

IMMUNOTHERAPY IN ALLERGIC RHINITIS

Research Article Quality of Life Improvement with Sublingual Immunotherapy: A Prospective Study of Efficacy

Allergic rhinitis is a common worldwide disease that

journal Current status of sublingual immunotherapy in the United States Shelby Elenburg and Michael S Blaiss *

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Sublingual immunotherapy (SLIT) vs. Subcutaneous immunotherapy (SCIT) Canonica G.W. Personalized Medicine Clinic Asthma & Allergy.

WILLIAM B. COBB, M.D. KEITH MATHENY, M.D. EWEN TSENG, M.D. KENNY CARTER, M.D.

allergy Asia Pacific Effect on quality of life of the mixed house dust mite/weed pollen extract immunotherapy Original Article Lisha Li and Kai Guan *

Sublingual Immunotherapy as a Technique of Allergen Specific Therapy

Current and Future Prospects for the Treatment of Food Allergy

Authors should appear in this order for PubMed:

Allergy Immunotherapy: A New Role for the Family Physician

According to the 2009 National Health Interview Survey, 7.8% of

A world leader in allergy immunotherapy

Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose

Insect allergy PHILLIP L. LIEBERMAN, MD

ALLERGY TESTING AND TREATMENT

See Important Reminder at the end of this policy for important regulatory and legal information.

Allergen Immunotherapy

Why does the body develop allergies?

Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW

LEARN ABOUT ANOTHER WAY TO TREAT YOUR ALLERGIES

John Bostock. Novel Immunotherapy Modalities. Catharrus aestivus. University Hospital Zürich. Thomas M. Kündig Dermatology Zurich University Hospital

immunotherapy to parietaria. A controlled field study

Transcription:

Use of SLIT in allergy practice: Is it ready for prime time? Stanley Fineman, MD, MBA Atlanta Allergy & Asthma Clinic AAIFNC, Feb 7, 2015

Disclosures Speakers bureau/consultant: AZ, Genentech/Novartis, Meda, Merck, Mylan, Nestle, Teva Clinical research: Genentech, Meda, Teva

Learning objectives: Discuss historical use of SLIT. Understand logistics of offering SLIT in allergy practice. Evaluate risks and benefits of offering SLIT in allergy practice.

Outline Why offer SLIT? How do we mix? How do we charge? Pros & Cons Should you offer this to your patients?

Why offer SLIT

Dr Cox: AAAAI 2006

Dr Cox: AAAAI 2006

JACI 2011;127:S1-S55

JACI 2011;127:S1-S55

Clinical trials, irrespective of their design, of SLIT in the treatment of respiratory and food allergy in patients 18 years or younger were selected (29 of 56 articles). Quality of each trial and total quality of compounded evidence was analyzed with the Grading of Recommendations Assessment, Development and Evaluation system. Annals Allergy Asthma Immunol 2013;110:402-415

What did they report? Of 56 articles, 29 met the inclusion criteria. Evidence is robust for the pre-coseasonal tablet and drop grass pollen SLIT efficacy in allergic rhinitis and for seasonal allergic asthma For house dust mite (HDM) SLIT in asthma, there is highquality evidence for medication reduction while maintaining symptom control Evidence for HDM SLIT efficacy in allergic rhinitis is of moderate-low quality. There is moderate evidence for efficacy of dual grass pollen and HDM SLIT after 12 months of treatment and 1 year after discontinuation in AR No anaphylaxis was found among 2469 treated children Some evidence for Alternaria SLIT efficacy is appearing Annals Allergy Asthma Immunol 2013;110:402-415

March 2013

JACI Pract 2014;2:144-9

What is the trend now?

Specialty Distribution by Type of Immunotherapy Provided Annals Allergy 2014;112:322-328 Subcutaneous N=199; Sublingual N=62. These Ns represent those providers who provide IT (IT17a) and who did not indicate that they had no patients on subcutaneous (IT18a) or sublingual (IT19a) IT. Ns by specialty are shown in parentheses with subcutaneous first. 24

Annals Allergy 2013;110:194-197

Annals Allergy 2013;110:194-197

Are pts more likely to use SLIT?

Children s compliance with allergen immunotherapy according to administration routes. Panjo, et al; Letter JACI JACI 2005;116:1380-81

Children s compliance with allergen immunotherapy according to administration routes. Panjo, et al; Letter JACI JACI 2005;116:1380-81

More Italian experience JACI 2010; 126:668-9

Persistence with Specific Immunotherapy (SCIT & SLIT) Among AR Patients in A US Allergy Practice Anolik et al AAAAI San Antonio 2013 Methods: Data from a retrospective chart review study of allergic rhinitis patients managed at a group allergy practice in the US initiating subcutaneous immunotherapy (SCIT) or sublingual immunotherapy (SLIT) from 2005-2011 were analyzed.

Persistence with SCIT & SLIT with AR pts Anolik et al: Results A total of 3,182 patients were identified, 78% chose SCIT and 22% chose SLIT Only 32.5% of patients completed treatment; 35% of SCIT and 23.7% of SLIT patients Median time on therapy was longer for SCIT patients (3.6 years) versus SLIT patients (2.6 years) Similar patterns were seen among children AAAAI 2013

Review of previous studies: 55%-82% of pts abandon SLIT before completing recommended course (3-5 year) Recommend: Communication improvement Educational tools F/U visits Telecommunication techniques JACIinPract 2014;2:152-155

JACIinPract 2014;2:156-160

JACIinPract 2014;2:156-160

How do we mix?

Logistics Glass dropper bottles w/ metered dose pump Delivers 0.05 ml per drop (50 mcl) Bottles have 15 ml capacity Fill to 8 ml Sterile 50% glycerine used as diluent Maintenance dose if 0.25 ml (5 drops) per day Each 8 ml maintenance bottle lasts a month

Logistics, continued Start with two build-up vials and one maintenance vial Build-up vials are 10-fold serial dilutions of the maintenance concentration (ie 1:10 w/v & 1:100 w/v) Dose in the mornings Hold drops under tongue for 2-3 minutes Patient may swallow or spit after 2 minutes Do not eat or drink for 5-10 minutes after dosing

Treatment Schedule Maintenance vials: 5 drops/ day Adjust dose if more than 4 doses are missed

Costs of Extracts at AAAC Extract Cost/50 ml Amount in vial Cost in Vial HDM mix, 10,000 AU $143 1 ml $2.86 Cat 10, 000 BAU $180 1.5 ml $5.46 Birch 1:20 w/v $93 1.25 ml $2.33 Oak 1:20 w/v $93 1 ml $1.86 Mixed Ragweed 1:20 $93 1.5 ml $2.79 Bermuda, 10,000 BAU $80 0.75 ml $1.20 Timothy 100,000 BAU $77 0.75 $1.20 Diluent 50% glycerin $2 Max total cost $18.00

How many pts have ordered SLIT? April 2013 Dec 2013 Jan 2014 Dec 2014 53 pts 86 pts

Pros & Cons of SLIT Safety Fewer systemic reactions than SCIT Some local/oral reactions Efficacy Many studies showing efficacy Some question about multiple allergen efficacy Convenience Not an injection Administered at home

Pros & Cons of SLIT Not FDA-approved for drops No clear-cut established protocol Costs for patient all out of pocket for drops Tablets covered as a pharmacy benefit Pts need to be trained to recognize and treat anaphylaxis Epinephrine autoinjector for all patients

Outline Why offer SLIT? How do we mix? How do we charge? Pros & Cons Should you offer this to your patients?

Which way is best for you?